Anavex Life Sciences Corp. (AVXL)
NASDAQ·Healthcare·Biotechnology
$2.65
+5.08%
Mkt Cap $231.68M
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+315.9%
Consensus $11.00 vs current $2.65
NASDAQ·Healthcare·Biotechnology
$2.65
+5.08%
Mkt Cap $231.68M
Buy
8
Hold
0
Sell
0
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
+315.9%
Consensus $11.00 vs current $2.65